|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Veliparib>> Market Analysis Reports |
Market Analysis Reports of Veliparib |
|
CAS 912444-00-9 Veliparib Chemical Report & Database ... Consumption Report & Database definitions: Name: Veliparib: Veliparib; 2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide Synonyms ... -00-9 APPLICATIONS: Chemical or Reaction Intermediate The Veliparib Report & Database gives Market Consumption ... PARP Inhibitors Market Size, Trends, Analysis, and Outlook By Drug (Talazoparib, Veliparib, Olaparib, Others), By Indication (Ovarian Cancer, Fallopian Tube Cancer, Breast Cancer, Others), By End-User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 ... PARP Inhibitors market By Drug (Talazoparib, Veliparib, Olaparib, Others), By Indication (Ovarian Cancer ... Poly Adp-Ribose Polymerase (Parp) Inhibitor Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Talazoparib, Veliparib, Olaparib, Other Drug Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application, By End Users ... Market Segmentation By Drug Type Talazoparib Veliparib Olaparib Other Drug Types By Distribution ... Global Market Report of ABT888 (CAS 912444-00-9) December 2024 Non-Small Cell Lung Cancer: KOL Insight ... , Array’s/AstraZeneca’s selumetinib and AbbVie’s veliparib). How the treatment landscape for ... Ovarian Cancer [2017] ... full list now > Phase III Veliparib (ABT-888; AbbVie) Atezolizumab (Tecentriq ... Colorectal Cancer [2017] ... ) OncoVAX (Vaccinogen) Early Stage MOAs (P1/P2) Veliparib (ABT-888; AbbVie) Entinostat (Syndax ... Glioblastoma: KOL Insight ... in GBM? What do KOLs think of AbbVie’s veliparib, AstraZeneca’s olaparib and BeiGene’s BGB ... ; AbbVie) dianhydrogalactitol (VAL-083; DelMar) veliparib (AbbVie) flucytosine (Toca FC; Tocagen) Imfinzi ... Ovarian Cancer: KOL Insight ... (bevacizumab; Roche) Phase III Therapies Veliparib (ABT-888; AbbVie Atezolizumab (Tecentriq ... CAS 912445-05-7 ABT-888 Chemical Report & Database ... -2-pyrrolidinyl]-1H-benzimidazole-4-carboxamide dihydrochloride; Veliparib dihydrochloride Synonyms: 2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H- ... benzimidazole-4-carboxamide dihydrochloride; Veliparib dihydrochloride Chemical Registry number: ... Anaplastic Astrocytoma - Pipeline Review, 2019 ... carmustine Carboplatin Vinchristine sulfate Leflunomide Veliparib Dabrafenib TAS-120 CB-839 Selumetinib ... Global RNA Polymerase Inhibitor Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 ... markets. Market segment by Type, covers Veliparib Rucaparib Talazoparib Niraparib Others Market ... Global RNA Polymerase Inhibitor Market Growth 2023-2029 ... countries. Market Segmentation: Segmentation by type Veliparib Rucaparib Talazoparib Niraparib Others Segmentation ... Global PARP Inhibitor Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect ... into: Lynparza Niraparib Rucaparib Talazoparib Veliparib Others In Chapter 6 and Chapter 7.4, based ... Global Poly (ADP-Ribose) Polymerase (PARP) Inhibitors Market Growth 2024-2030 ... and countries. Segmentation by Type: Talazoparib Veliparib Olaparib Other Segmentation by Application: Ovarian ... 2025-2030 Global Poly (ADP-Ribose) Polymerase (PARP) Inhibitors Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region ... Teva Pharmaceutical Industries By Type Talazoparib Veliparib Olaparib Other By Application Ovarian Cancer ... Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review ... Orphan Drugs: Market Research Report This report analyzes the worldwide markets for Orphan Drugs in US$ Million by the following Product Segments: Biologics, and Non-Biologics. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates ... Breast Cancer: New targeted therapies transform treatment - KOL Insight The introduction of targeted therapies revolutionised the breast cancer market, widening clinical options and bringing improved survival rates and lower side effects for patients. Now the sector is set for further positive change and expansion as next ... Breast Cancer: KOL Insight [2018] ... ; Pfizer) Zejula (niraparib; Tesaro/Merck & Co.) veliparib (ABT 888; AbbVie) Keytruda (pembrolizumab ... |